Zaanan Study supervision: P. Laurent-Puig, V. Taly, A. Zaanan Grant Support This work was supported by the Minist ere de l'Enseignement Sup erieur et de la Recherche, the Universit e Paris-Descartes, the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sant e et de la Recherche M edicale (INSERM), the Institut National du Cancer (INCA, n 2009-1-RT-03-US-1 and 2009-RT-03-UP5-1), the Association pour la recherche contre le cancer (ARC, no. SL220100601375), the Agence Nationale de la Recherche ,
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, vol.136, pp.359-86, 2015. ,
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer, Ann Oncol, vol.27, pp.1386-422, 2016. ,
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1), Eur J Cancer, vol.45, pp.228-275, 2009. ,
RECIST: no longer the sharpest tool in the oncology clinical trials toolbox-point, Cancer Res, vol.72, pp.5145-5154, 2012. ,
Variability in assessing treatment response: metastatic colorectal cancer as a paradigm, Clin Cancer Res, vol.20, pp.3560-3568, 2014. ,
Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines, Eur J Cancer, vol.39, pp.718-745, 2003. ,
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use, Eur J Cancer, vol.43, pp.1348-60, 2007. ,
Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to oxaliplatin combination chemotherapy: implications for tumor marker monitoring and guidelines, J Clin Oncol, vol.21, pp.4466-4473, 2003. ,
Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer, Cancer Invest, vol.23, pp.338-51, 2005. ,
Prognostic and Predictive Biomarkers in Colorectal Cancer. From the Preclinical Setting to Clinical Practice, Curr Cancer Drug Targets, vol.15, pp.703-718, 2015. ,
Detection of circulating tumor DNA in early-and late-stage human malignancies, Sci Transl Med, vol.6, pp.224-248, 2014. ,
Analysis of circulating tumor DNA to monitor metastatic breast cancer, N Engl J Med, vol.368, pp.1199-209, 2013. ,
Colorectal cancer: Liquid biopsy enables real-time monitoring of molecular alterations in CRC, Nat Rev Gastroenterol Hepatol, vol.12, p.372, 2015. ,
Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial, Lancet Oncol, vol.16, pp.937-985, 2015. ,
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer, Ann Oncol, vol.26, pp.1715-1737, 2015. ,
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers, Nature, vol.486, pp.537-577, 2012. ,
Clinical relevance of KRAS-mutated subclones detected with picodroplet digital PCR in advanced colorectal cancer treated with anti-EGFR therapy, Clin Cancer Res, vol.21, pp.1087-97, 2015. ,
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients, Nat Med, vol.21, pp.795-801, 2015. ,
Detection and quantification of mutations in the plasma of patients with colorectal tumors, Proc Natl Acad Sci U S A, vol.102, pp.16368-73, 2005. ,
Cell-free nucleic acids as biomarkers in cancer patients, Nat Rev Cancer, vol.11, pp.426-463, 2011. ,
Detecting biomarkers with microdroplet technology, Trends Mol Med, vol.18, pp.405-421, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-02299585
Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients, Clin Chem, vol.59, pp.1722-1753, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-02299581
Liquid biopsies: genotyping circulating tumor DNA, J Clin Oncol, vol.32, pp.579-86, 2014. ,
A study of hypermethylated circulating tumor DNA as a universal colorectal cancer biomarker, Clin Chem, vol.62, pp.1129-1168, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02295782
Sensitive digital quantification of DNA methylation in clinical samples, Nat Biotechnol, vol.27, pp.858-63, 2009. ,
Adequate sample size for developing prediction models is not simply related to events per variable, J Clin Epidemiol, vol.76, pp.175-82, 2016. ,
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy, Cancer Discov, vol.6, pp.479-91, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01872958
Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer, Int J Cancer, vol.135, pp.2984-91, 2014. ,
Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for bloodbased diagnosis of colorectal cancer, Clin Cancer Res Fanny Garlan, vol.13, pp.5416-5425, 2013. ,